MEDICAL ONCOLOGY AND HAEMATOLOGY
sub-menu:


SUPERVISING COMMITTEE

Definition

GENERAL PRINCIPLES

COMPONENTS OF TRAINING

Core Training

Non Core Training

Training Sites

Assessment

SPECIAL SOCIETIES

Vocational Training
Medical Oncology and Haematology
Supervising Committee
Specialist Advisory Committee (JSAC) in Medical Oncology.

Definition of Specialty
The paediatric oncologist/haematologist is a paediatrician with specialised skills in the clinical management of solid tumours, malignant and non malignant haematological diseases and with bone marrow transplantation in children and adolescents.

General Principles
  1. Advanced training in paediatric medical oncology and clinical haematology will be for at least 3 years following satisfactory completion of basic paediatric training and the FRACP Examination in Paediatrics.
  2. Training should encompass experience with a broad range of malignancies and an understanding of the place of appropriate methods of investigation, assessment and management. Trained paediatric haematologists/oncologists will take their place with radiation oncologists, surgeons, and other health care professionals in multidisciplinary programs to ensure optimal outcome for the child/adolescent and their family.
    • Trainees are expected to understand:
      • the biology and natural history of malignant disease
      • the management of all stages of common tumours
      • the current specialist literature
      • relevant techniques of clinical research.
  3. All subspecialty paediatric trainees must complete the community and child health requirements for paediatric training.
    Note that the guidelines differ between Australia and New Zealand.

Components of Training
Core Training
A minimum of 2 years is required. During this period the trainee shall:
  • acquire knowledge of the nature, pathology, natural history and epidemiology of haematological and malignant disease in children and adolescents;
  • gain experience in the methods of investigation and management of patients with these disorders, including clinical examination, laboratory investigation and diagnostic imaging;
  • acquire knowledge of the pharmacology, pharmacokinetics, use and side effects of antineoplastic drugs and other drugs relevant to these disorders;
  • obtain experience in the multi-disciplinary approach to management of children and adolescents with malignant disease or complicated haematological problems;
  • trainees are expected to achieve a high level of communication skills and to work within a multi-disciplinary environment. Trainees are encouraged to participate in training in communication skills, covering such areas as:
    • breaking bad news
    • discussing treatment options
    • clinical trials consent;
  • gain an understanding of the role of radiotherapy in the management of children and adolescents with malignant disease in particular:
    • an understanding of the basic principles of radiobiology
    • an understanding of the simulation and planning process
    • an understanding of the role of palliative radiotherapy
    • management of radiotherapy side effects;
  • gain an understanding of the role of surgery in the management of children and adolescents with malignant disease;
  • be proficient in the prevention and treatment of the complications of malignant disease and its treatments;
  • have an understanding of the potential late effects of treatment, e.g. neurocognitive development, growth and endocrine effects, psychosocial sequelae, and to participate in the long term follow up of patients;
  • gain experience in the role of haematopoietic stem cell transplantation in the management of malignant, haematological and metabolic disorders in children and adolescents;
  • acquire knowledge of and experience in palliative care, including knowledge of the pathophysiology and pharmacology of pain, constipation, nausea and vomiting, dyspnoea and other common symptom problems. There should be an understanding of the roles of the family, community and local health professionals caring for the child and family;
  • gain experience in the design, implementation and evaluation of clinical trials and protocols for the management of haematological and malignant disease in children and adolescents;
  • develop an understanding of the appropriate methods of statistical design and analysis. This should enable the trainee to evaluate research reports with an appropriate depth of understanding.

Non Core Training
Trainees may spend 12 months in a non core (elective) position. This period may be used to gain further clinical or laboratory experience in related specialities or to undertake a period of research in a field of direct relevance to paediatric haematology and oncology. For example, this year could constitute one year of full time research towards an MD or PhD.

  Medical Oncology next >>

[ Table of Contents ]


 
  HOME  |  INTRODUCTION  |  BASIC TRAINING  |  EXAMINATIONS  |  ADVANCED TRAINING  |  CONTACTS  

Copyright 2003 © The Royal Australasian College of Physicians
This page was last edited: 5 November 2003